상세 보기
Long-term responders from the Phase 3 dreamm-7 study of belantamab mafodotin plus bortezomib and dexamethasone vs daratumumab plus bortezomib and dexamethasone in Relapsed/Refractory multiple myeloma
- Hungria, Vania;
- Robak, Pawel;
- Hus, Marek;
- Zherebtsova, Vera;
- Ward, Christopher;
- ... Kim, Kihyun;
- 외 19명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Long-term responders from the Phase 3 dreamm-7 study of belantamab mafodotin plus bortezomib and dexamethasone vs daratumumab plus bortezomib and dexamethasone in Relapsed/Refractory multiple myeloma
- 저자
- Hungria, Vania; Robak, Pawel; Hus, Marek; Zherebtsova, Vera; Ward, Christopher; Ho, Phoebe Joy; Hajek, Roman; Kim, Kihyun; Grosicki, Sebastian; Sia, Hanlon; Bryant, Adam; de Lacerda, Marcelo Pitombeira; Martinez, Gracia; Balari, Anna Sureda; Mielnik, Micha; Nichols, Maureen; Mouro, Jorge; Khalaf, Zeyad; Baig, Hena; Polinkovsky, Margaret; Pirooz, Nick; Varghese, Sybil; Lee, Joe; Eccersley, Lydia; Mateos, Maria-Victoria
- 발행일
- 2025-11-03
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146
- 페이지
- 2262 ~ 2263